Everence Capital Management Inc. cut its holdings in Globe Life Inc. (NYSE:GL - Free Report) by 71.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,370 shares of the company's stock after selling 8,430 shares during the quarter. Everence Capital Management Inc.'s holdings in Globe Life were worth $376,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. D. E. Shaw & Co. Inc. increased its stake in Globe Life by 398.7% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 1,074,628 shares of the company's stock valued at $88,420,000 after purchasing an additional 859,146 shares in the last quarter. Millennium Management LLC raised its position in shares of Globe Life by 177.0% during the 2nd quarter. Millennium Management LLC now owns 1,279,818 shares of the company's stock worth $105,303,000 after purchasing an additional 817,760 shares during the last quarter. Nuance Investments LLC grew its holdings in Globe Life by 155.6% during the 3rd quarter. Nuance Investments LLC now owns 1,138,978 shares of the company's stock valued at $120,629,000 after buying an additional 693,346 shares during the last quarter. International Assets Investment Management LLC boosted its stake in shares of Globe Life by 15,398.7% during the third quarter. International Assets Investment Management LLC now owns 336,631 shares of the company's stock valued at $356,530,000 after acquiring an additional 334,459 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Globe Life by 22.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company's stock valued at $160,949,000 after purchasing an additional 277,108 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company's stock.
Insider Transactions at Globe Life
In other news, CEO Frank M. Svoboda sold 14,340 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total value of $1,560,192.00. Following the transaction, the chief executive officer now directly owns 16,396 shares in the company, valued at approximately $1,783,884.80. This trade represents a 46.66 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CMO Jennifer Allison Haworth sold 9,000 shares of the business's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the sale, the chief marketing officer now directly owns 13,485 shares of the company's stock, valued at approximately $1,522,591.35. This represents a 40.03 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,788 shares of company stock valued at $4,429,779. Insiders own 1.51% of the company's stock.
Wall Street Analyst Weigh In
GL has been the topic of several research analyst reports. Wells Fargo & Company raised their target price on shares of Globe Life from $108.00 to $117.00 and gave the stock an "overweight" rating in a research report on Thursday, October 10th. Raymond James boosted their target price on Globe Life from $160.00 to $188.00 and gave the stock a "strong-buy" rating in a report on Tuesday, October 15th. Truist Financial boosted their price objective on shares of Globe Life from $90.00 to $105.00 and gave the stock a "hold" rating in a research note on Friday, October 25th. Keefe, Bruyette & Woods raised their target price on shares of Globe Life from $120.00 to $125.00 and gave the company an "outperform" rating in a research note on Tuesday, October 29th. Finally, TD Cowen began coverage on Globe Life in a report on Wednesday, October 9th. They issued a "buy" rating and a $150.00 price target for the company. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $127.10.
Get Our Latest Report on Globe Life
Globe Life Stock Up 0.3 %
GL traded up $0.36 on Tuesday, reaching $111.56. The company's stock had a trading volume of 571,217 shares, compared to its average volume of 667,129. Globe Life Inc. has a 1 year low of $38.95 and a 1 year high of $132.00. The business's 50 day moving average is $108.57 and its 200 day moving average is $101.59. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The stock has a market cap of $9.36 billion, a price-to-earnings ratio of 9.44 and a beta of 0.80.
Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, October 23rd. The company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.06 by $0.43. The company had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.46 billion. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. The business's revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.71 EPS. As a group, research analysts forecast that Globe Life Inc. will post 12.31 EPS for the current fiscal year.
Globe Life Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Monday, January 6th will be paid a $0.24 dividend. The ex-dividend date of this dividend is Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.86%. Globe Life's dividend payout ratio (DPR) is presently 8.12%.
Globe Life Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report